Who owns Biolinerx Ltd sponsored ads?
- Ticker: BLRX
- CUSIP Number: 09071m205
Tip: Access positions for across all investors
Analyze quarterly positions in Biolinerx with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Biolinerx stock
Who bought or sold Biolinerx Ltd sponsored ads this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Susquehanna International | 377k | $422k | 11% | Mar 2024 |
|
Morgan Stanley | 291k | $326k | 66% | Mar 2024 |
|
Values First Advisors | 204k | $228k | 290% | Mar 2024 |
|
LPL Financial | 100k | $112k | -12% | Mar 2024 |
|
Atria Wealth Solutions | 99k | $111k | -10% | Mar 2024 |
|
Pvg Asset Management | 62k | $97k | 100% | Dec 2023 |
|
Envestnet Asset Management | 54k | $61k | -6% | Mar 2024 |
|
Geode Capital Management | 40k | $45k | 25% | Mar 2024 |
|
Rathbones Brothers | 40k | $45k | 0% | Mar 2024 |
|
Geneos Wealth Management | 39k | $43k | -5% | Mar 2024 |
|
Citadel Advisors | 36k | $41k | -44% | Mar 2024 |
|
Wells Fargo & Company | 32k | $36k | 275% | Mar 2024 |
|
XTX Topco | 32k | $35k | 35% | Mar 2024 |
|
National Asset Management | 21k | $39k | 10% | Mar 2024 |
|
Rhumbline Advisers | 18k | $21k | -2% | Mar 2024 |
|
Cetera Investment Advisers | 18k | $20k | 21% | Mar 2024 |
|
Two Sigma Securities | 17k | $19k | 100% | Mar 2024 |
|
Cutter & CO Brokerage | 17k | $19k | 0% | Mar 2024 |
|
Qube Research & Technologies | 14k | $16k | 39429% | Mar 2024 |
|
Creative Planning | 13k | $15k | -11% | Mar 2024 |
|
UBS Group | 13k | $14k | 4090% | Mar 2024 |
|
Nemes Rush Group | 12k | $13k | 0% | Mar 2024 |
|
Gradient Investments | 9.0k | $10k | 374% | Mar 2024 |
|
Goss Wealth Management | 4.3k | $4.8k | 0% | Mar 2024 |
|
GAMMA Investing | 4.0k | $4.5k | 100% | Mar 2024 |
|
Group One Trading | 3.2k | $3.6k | 100% | Mar 2024 |
|
Simplex Trading | 2.0k | $2.0k | 100% | Mar 2024 |
|
Advisor Group Holdings | 1.2k | $1.2k | -92% | Mar 2024 |
|
Tradewinds Capital Management | 200.00 | $224.000000 | 0% | Mar 2024 |
|
Royal Bank of Canada | 66.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Biolinerx?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Dec 2023 | 30k | $48k |
Jpmorgan Chase & Co | Dec 2023 | 23k | $36k |
NorthRock Partners | Dec 2023 | 17k | $27k |
Allen Mooney & Barnes Investment Advisors | Dec 2023 | 15k | $24k |
Ronald Blue Trust | Dec 2023 | 117.00 | $0 |